ArticleHaematologica2024

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Rabia Shahswar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.